Shares of Recursion Pharmaceuticals (NASDAQ: RXRX) were skyrocketing around 20% higher as of 11 a.m. ET on Friday. The big gain for the biotech stock came after the U.S. Food and Drug ...

Shares of micro-cap pharma stock surged nearly 4 percent after the company secured a significant order worth Rs.15–18 crores from the Tamil Nadu Medical Services Corporation (TNMSC) for the supply of ...

Shares of Biocon will be in focus in Friday after the pharma major said its subsidiary ... Bevacizumab for intravenous use. Biocon stock ended 5.33% lower at Rs 305.20 on Wednesday against the ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on April 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an ...

Thursday, Piper Sandler reiterated an Overweight rating on BridgeBio Pharma (NASDAQ:BBIO) with a price target of $46.00, aligning with the broader Wall Street sentiment. According to InvestingPro ...

Major stock markets closed with some of the highest ... day's closing on Wednesday were the third highest in the S&P 500's history since beginning in 1957. The last time the index had gains ...

Amid a broader selloff in the biopharma sector on Wednesday, Jazz Pharmaceuticals (NASDAQ:JAZZ) dropped ~6% after announcing a $145M settlement to resolve certain antitrust claims filed regarding ...

Indian pharma stocks, including Sun Pharmaceutical Industries, Gland Pharma, Lupin and others traded sharply lower on Wednesday after the US President Donald Trump said he will soon announce a ...

Avoid the stress of overpaying for a stock or missing an opportunity by using ... by its relative strength Before we jump into Ascentage Pharma Group International’s stock price, history, target price ...